Clinical Trial: Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07345559) titled 'Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock' on Nov. 27, 2025.

Brief Summary: Cardiogenic shock is a life-threatening condition characterized by inadequate cardiac output, leading to organ hypoperfusion and high mortality. Maintaining mean arterial pressure (MAP) is crucial, but standard targets may be insufficient due to venous congestion. Central venous pressure (CVP) can help assess effective perfusion pressure. This study investigates whether a personalized MAP target adjusted by CVP improves organ function and survival compared to standard MAP management.

Study Start Date: Dec. 15, 2025 ...